Articles

BHS 2013 recommendations for treatment of myelodysplastic syndromes

BJH - volume 6, issue 2, may 2015

S. Meers MD, PhD, D. Breems MD, PhD, G. Bries MD, PhD, M. Delforge MD, PhD, C. Graux MD, PhD, D. Selleslag MD, L. Noens MD, PhD

Summary

The guidelines on the current state-of-the-art in the diagnosis and treatment of myelodysplastic syndromes of the Belgian Hematological Society working group on myelodysplastic syndromes were published in 2013.1 The key points of these guidelines are presented in two issues of the Belgian Journal of Hematology. In this paper we present the optimal treatment of patients with myelodysplastic syndromes within the current limitations of Belgian reimbursement modalities.

(BELG J HEMATOL 2015;6(2):54–60)

Read more

The 2013 Belgian Hematological Society recommendations for the diagnosis and classification of myelodysplastic syndromes

BJH - volume 6, issue 1, march 2015

S. Meers MD, PhD, D. Breems MD, PhD, G. Bries MD, PhD, M. Delforge MD, PhD, C. Graux MD, PhD, D. Selleslag MD, L. Noens MD, PhD

Summary

The Belgian Hematological Society working group on myelodysplastic syndromes published their guidelines on the state of the art in diagnosis and treatment of myelodysplastic syndromes and the key points of these recommendations are presented in two issues of the Belgian Journal of Hematology.1 In this first paper we present the requirements for a correct diagnosis and classification of patients with myelodysplasia.

(BELG J HEMATOL 2015;6(1):10–5)

Read more

O.2 Analysis of Phenotype and Outcome in Essential Thrombocythemia with CALR and JAK2 mutations

BJH - volume 6, issue Abstract Book BHS, january 2015

C. AL Assaf , F. Van Obbergh MD, J. Billiet MD, E. Lierman PhD, T. Devos MD, PhD, C. Graux MD, PhD, A.S. Hervent , T. Tousseyn MD, PhD, P. De Paepe MD, PhD, P. Papadopoulos , L. Michaux MD, PhD, P. Vandenberghe MD, PhD

Read more

P2.04 Role of microvesicles derived from leukemic blast in DIC and thrombosis.

BJH - volume 6, issue Abstract Book BHS, january 2015

D. Gheldof , J-M. Dogné PhD, PharmD, C. Graux MD, PhD, G. Fabienne , A. Sonet MD, B. Chatelain PharmD, F. Mullier PhD, PharmD, C. Chatelain MD

Read more

P3.06 Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation following Flu-TBI versus TLI-ATG Conditioning

BJH - volume 6, issue Abstract Book BHS, january 2015

M. Hannon , Y. Beguin MD, PhD, G. Ehx , S. Servais MD, PhD, L. Seidel , C. Graux MD, PhD, J. Maertens MD, PhD, T. Kerre MD, PhD, C. Daulne , M. De Bock , M. Fillet , A. Ory , E. Willems MD, PhD, A. Gothot MD, PhD, S. Humblet-Baron , prof. F. Baron

Read more

O.3 Comparison of 2 nonmyeloablative regimens for allogeneic HCT: a phase II randomized study from the HCT committee of the BHS

BJH - volume 5, issue Abstract Book BHS, january 2014

prof. F. Baron , P. Zachée MD, PhD, J. Maertens MD, PhD, T. Kerre MD, PhD, A. Ory , L. Seidel , C. Graux MD, PhD, P. Lewalle MD, PhD, H. Schouten , K. Theunissen MD, R. Schots MD, PhD, Y. Beguin MD, PhD

Read more

O.8 JAK2 V617F-Negative AND MPL W515K/L-Negative Essential Thrombocythemia: a High Resolution SNP Array Study

BJH - volume 5, issue Abstract Book BHS, january 2014

C. AL Assaf , E. Lierman PhD, T. Devos MD, PhD, C. Graux MD, PhD, J. Billiet MD, J. Finalet Ferreiro , P. Vandenberghe MD, PhD

Read more